Team:Imperial College London/M1/PeptideDelivery

From 2009.igem.org

Revision as of 12:30, 12 October 2009 by Droche (Talk | contribs)

Contents

II09 Thumb m1.png Module 1: Protein Production Overview

Peptide Delivery

Many short chain peptide drugs are suseptible to breakdown in the stomach making them suitable candidates for encapsulation.

MethPep.png

When synthesised, all polypeptides begin with the same amino acid: methionine. This often removes the desired bioactivity of the compounds. Some larger polypeptides are cleaved by proteases within the body into smaller functional peptides that do not begin with methionine (as shown on the image to the left.)

Making use of the peptide processing pathways within the body, we propose a universal template that can be used for the synthesis of all short chain peptides. By encoding a linker region that is designed to be recognised and cleaved by proteases within the gut, we get past the production difficulties associated with peptides, and allow for the release of these peptides into the gut. What is more, our system does not require the expression any additional genes!


  About how our universal peptide processing system works.


Demonstration

Opiorphin

To showcase peptide delivery, we have selected the pentapeptide (five amino acids) opiorphin. Opiorphin is a good example of a bioactive peptide that is not easily manufactured.

This peptide is naturally found in human saliva and plays a role in pain relief and as a natural anti-depressant. The E.ncapsulator's unique peptide production module makes it an ideal chassis for the synthesis of opiorphin.


  About opiorphin.




Mr. Gene   Geneart   Clontech   Giant Microbes